Results 11 to 20 of about 179,664 (386)

Post‐Cardiac Arrest Hydrocortisone Use Ameliorates Cardiac Mitochondrial Injury in a Male Rat Model of Ventricular Fibrillation Cardiac Arrest

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Steroid use after cardiac arrest has been reported to improve survival and neurological outcome in cardiac arrest survivors. The study aimed to evaluate the effect of post‐arrest hydrocortisone use on myocardial damage and cardiac ...
Min‐Shan Tsai, Chien‐Hua Huang, Chen‐Hsu Wang, Hsaio‐Ju Cheng, Shih‐Ni Wu, Wei‐Tien Chang, Wen‐Jone Chen   +6 more
doaj   +1 more source

Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway

BMC Pharmacology and Toxicology, 2023
Background The anti-osteosarcoma effects of hydrocortisone and thiram, an inhibitor of type 2 11ß-hydroxysteroid dehydrogenase (11HSD2), have not been reported.
You Zhang, Nanjing Li, He Li, Maojia Chen, Wei Jiang, Wenhao Guo   +5 more
doaj   +1 more source

Association of mortality with fludrocortisone addition to hydrocortisone treatment among septic shock patients: a propensity score matching analysis

Frontiers in Medicine, 2023
BackgroundSeveral clinical trials of corticosteroids have been carried out in the treatment of septic shock, however, the therapeutic effect of the most widely used hydrocortisone is still controversial, and no studies have directly compared ...
Xiaoxiao Cheng, Zhiqin Fu, Yiting Liu, Xiaoyu Zheng, Tianyang Hu   +4 more
doaj   +1 more source

Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2021
Importance Sepsis is a common syndrome with substantial morbidity and mortality. A combination of vitamin C, thiamine, and corticosteroids has been proposed as a potential treatment for patients with sepsis. Objective To determine whether a combination
J. Sevransky, R. Rothman, D. Hager, G. Bernard, Samuel M. Brown, T. Buchman, L. Busse, C. Coopersmith, C. DeWilde, E. Ely, L. Eyzaguirre, A. Fowler, D. Gaieski, M. Gong, A. Hall, J. Hinson, M. Hooper, G. Kelen, Akram Khan, M. Levine, R. Lewis, C. Lindsell, Jessica S Marlin, A. McGlothlin, Brooks L. Moore, K. Nugent, S. Nwosu, C. Polito, T. Rice, E. Ricketts, C. Rudolph, Fred Sanfilippo, K. Viele, G. Martin, D. Wright   +34 more
semanticscholar   +1 more source

Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock [PDF]

, 2005
Stress doses of hydrocortisone a re known to have immunomodulatory effects in patients with hyperdynamic septic shock. The prognosis correlates with the presence and severity of septic encephalopathy. However, neurological evaluation is influenced by the
Anderson, Annane, Astudillo, Barie, Barie, Bastos, Bertsch, Blomquist, Bollaert, Bolton, Bolton, Bone, Briegel, Briegel, Briegel, Briegel, Danielson, Donato, Eidelman, Endo, Haimoto, Herrmann, Hollenberg, Hund, Hund, Jonsson, Keh, Lindner, Marshall, Metinko, Munck, Mussack, Mussack, Pelinka, Pelinka, Rosen, Schwarz, Stanimirovic, Usui, Vincent, Waage, Weiss, Westaby, Wheeler, Wiesmann, Wunderlich, Young   +46 more
core   +2 more sources

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants An ongoing
D. Angus, L. Derde, Farah Al-Beidh, D. Annane, Y. Arabi, A. Beane, Wilma van Bentum-Puijk, L. Berry, Zahra Bhimani, M. Bonten, C. Bradbury, F. Brunkhorst, M. Buxton, Adrian Buzgau, A. Cheng, M. D. de Jong, M. Detry, L. Estcourt, M. Fitzgerald, H. Goossens, Cameron Green, R. Haniffa, A. Higgins, Christopher M. Horvat, Sebastiaan J. Hullegie, P. Kruger, F. Lamontagne, P. Lawler, K. Linstrum, E. Litton, E. Lorenzi, J. Marshall, D. McAuley, Anna McGlothin, S. McGuinness, B. McVerry, S. Montgomery, P. Mouncey, S. Murthy, A. Nichol, R. Parke, Jane C. Parker, K. Rowan, A. Sanil, Marlene S. Santos, Christina T. Saunders, Christopher Seymour, Anne M Turner, F. L. van de Veerdonk, B. Venkatesh, R. Zarychanski, S. Berry, R. Lewis, C. McArthur, S. Webb, A. Gordon   +55 more
semanticscholar   +1 more source

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.

New England Journal of Medicine, 2022
BACKGROUND Bronchopulmonary dysplasia is a prevalent complication after extremely preterm birth. Inflammation with mechanical ventilation may contribute to its development.
Kristi L. Watterberg, M. Walsh, Lei Li, Sanjay Chawla, C. D’Angio, Ronald N. Goldberg, S. Hintz, M. Laughon, B. A. Yoder, K. Kennedy, G. McDavid, C. Backstrom-Lacy, Abhik Das, Margaret M. Crawford, Martin Keszler, G. Sokol, B. B. Poindexter, Namasivayam Ambalavanan, A. Hibbs, William E. Truog, Barbara Schmidt, M. Wyckoff, Amir M. Khan, M. Garg, P. R. Chess, A. Reynolds, M. Moallem, Edward F. Bell, Lauritz R. Meyer, Ravi M. Patel, K. V. van Meurs, C. Cotten, E. C. McGowan, A. Hines, S. Merhar, M. Peralta-Carcelen, D. Wilson-Costello, H. Kilbride, S. Demauro, R. Heyne, Ricardo A. Mosquera, G. Natarajan, I. Purdy, Jean R Lowe, Nathalie L. Maitre, H. Harmon, L. Hogden, I. Adams-Chapman, Sarah Winter, W. Malcolm, R.D. Higgins   +50 more
semanticscholar   +1 more source

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia

Journal of Clinical Endocrinology and Metabolism, 2021
Context Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes.
Merke Dp, M. A, A. W, B. a, L. A., Juul A, Newell-Price J, Perry Cg, Prete A, Rees Da, Reisch N, Stikkelbroeck N, Touraine P, Maltby K, T. Fp, P. J, Rosser Rj   +16 more
semanticscholar   +1 more source

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance Coronavirus disease 2019 (COVID-19) is associated with severe lung damage. Corticosteroids are a possible therapeutic option. Objective To determine the effect of hydrocortisone on treatment failure on day 21 in critically ill patients with ...
P. Dequin, N. Heming, F. Meziani, G. Plantefeve, G. Voiriot, J. Badie, B. François, C. Aubron, J. Ricard, S. Ehrmann, Y. Jouan, A. Guillon, M. Leclerc, Carine Coffre, H. Bourgoin, C. Lengellé, Caroline Caille-Fénérol, E. Tavernier, S. Zohar, B. Giraudeau, D. Annane, A. Le Gouge   +21 more
semanticscholar   +1 more source

Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance It is unclear whether vitamin C, hydrocortisone, and thiamine are more effective than hydrocortisone alone in expediting resolution of septic shock.
T. Fujii, N. Luethi, P. Young, D. Frei, G. Eastwood, C. French, A. Deane, Y. Shehabi, L. Hajjar, G. Oliveira, A. Udy, N. Orford, S. Edney, A. Hunt, H. Judd, L. Bitker, L. Cioccari, T. Naorungroj, Fumitaka Yanase, S. Bates, F. McGain, Elizabeth P Hudson, W. Al-Bassam, D. Dwivedi, C. Peppin, P. Mccracken, J. Orosz, M. Bailey, R. Bellomo   +28 more
semanticscholar   +1 more source